Disclosure Of Interests In Other Entities [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023734

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	As at 2019-12-31
Disclosure of interests in other entities [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of interests in subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests	—	—	—	—	—	—	- BGN	—	—	—	- BGN	—	—	—	—	—	—
Non-controlling interests	—	- BGN	—	—	—	—	—	—	—	- BGN	—	—	—	—	—	—	—
Current assets	—	70 659 BGN	—	—	—	—	—	—	—	71 005 BGN	—	—	—	—	—	—	—
Non-current assets	—	46 798 BGN	—	—	—	—	—	—	—	46 306 BGN	—	—	—	—	—	—	—
Current liabilities	—	15 740 BGN	—	—	—	—	—	—	—	17 111 BGN	—	—	—	—	—	—	—
Non-current liabilities	—	2 898 BGN	—	—	—	—	—	—	—	3 064 BGN	—	—	—	—	—	—	—
Revenue	—	—	—	—	—	—	42 431 BGN	—	—	—	40 105 BGN	—	—	—	—	—	—
Profit (loss)	- BGN	—	- BGN	- BGN	- BGN	1 396 BGN	1 396 BGN	1 396 BGN	604,000 BGN	—	604,000 BGN	- BGN	- BGN	604,000 BGN	- BGN	- BGN	—
Comprehensive income	- BGN	—	- BGN	287,000 BGN	- BGN	1 683 BGN	1 683 BGN	1 396 BGN	604,000 BGN	—	593,000 BGN	- BGN	- BGN	593,000 BGN	11,000 BGN	- BGN	—
Disclosure of interests in associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income	- BGN	—	- BGN	287,000 BGN	- BGN	287,000 BGN	287,000 BGN	- BGN	- BGN	—	11,000 BGN	- BGN	- BGN	11,000 BGN	11,000 BGN	- BGN	—
Disclosure of interests in joint arrangements [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents	—	57,000 BGN	—	—	—	—	—	—	—	64,000 BGN	—	—	—	—	—	—	40,000 BGN
Depreciation and amortisation expense	—	—	—	—	—	—	3 877 BGN	—	—	—	4 231 BGN	—	—	—	—	—	—
Tax expense (income)	—	—	—	—	—	—	168,000 BGN	—	—	—	20,000 BGN	—	—	—	—	—	—